russ2000_2_0044|AQST|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
russ2000_2_0044|AQST|1|Aquestive Therapeutics Inc Total Current Assets (Quarterly) (USD)|Aquestive Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Aquestive Therapeutics Inc Inventories (Quarterly) (USD)|Aquestive Therapeutics Inc Net PP&E (Quarterly) (USD)|Aquestive Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Aquestive Therapeutics Inc Total Liabilities (Quarterly) (USD)|Aquestive Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Aquestive Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Aquestive Therapeutics Inc Total Deposits (Quarterly) (USD)|Aquestive Therapeutics Inc Book Value (Quarterly) (USD)|Aquestive Therapeutics Inc Retained Earnings (Quarterly) (USD)|Aquestive Therapeutics Inc Treasury Stock (Quarterly) (USD)|Aquestive Therapeutics Inc EV to Revenues|Aquestive Therapeutics Inc EV to Earnings|Aquestive Therapeutics Inc EV to Free Cash Flow|Aquestive Therapeutics Inc EV to Assets (Quarterly)|Aquestive Therapeutics Inc PS Ratio|Aquestive Therapeutics Inc PE Ratio|Aquestive Therapeutics Inc Price to Book Value|Aquestive Therapeutics Inc PEG Ratio|Aquestive Therapeutics Inc Debt to Equity Ratio|Aquestive Therapeutics Inc Dividend Yield|Aquestive Therapeutics Inc Shareholder Yield (TTM)|Aquestive Therapeutics Inc Percent of Shares Outstanding Short|Aquestive Therapeutics Inc Total Receivables (Quarterly) (USD)|Aquestive Therapeutics Inc Total Payables (Quarterly) (USD)|Aquestive Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Aquestive Therapeutics Inc Return on Invested Capital|Aquestive Therapeutics Inc Quality Ratio Score|Aquestive Therapeutics Inc Momentum Score|Aquestive Therapeutics Inc Beta (1Y)|Aquestive Therapeutics Inc Sustainable Growth Rate (TTM)|Aquestive Therapeutics Inc Institutional Investor Ownership Percentage|Aquestive Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Aquestive Therapeutics Inc Total Employees (Annual)|Aquestive Therapeutics Inc EPS Diluted (Quarterly) (USD)|Aquestive Therapeutics Inc SG&A Expense (Quarterly) (USD)|Aquestive Therapeutics Inc Shares Outstanding|Aquestive Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Aquestive Therapeutics Inc Ordinary Shares Number (Quarterly)|Aquestive Therapeutics Inc Payout Ratio|Aquestive Therapeutics Inc Quick Ratio (Quarterly)|Aquestive Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Aquestive Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Aquestive Therapeutics Inc Effective Tax Rate (TTM)|Aquestive Therapeutics Inc Return on Equity|Aquestive Therapeutics Inc Net Income (TTM) (USD)|Aquestive Therapeutics Inc Revenue (TTM) (USD)|Aquestive Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Aquestive Therapeutics Inc Revenue (Quarterly) (USD)|Aquestive Therapeutics Inc Gross Profit (Quarterly) (USD)|Aquestive Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Aquestive Therapeutics Inc Net Income (Quarterly) (USD)|Aquestive Therapeutics Inc Net Interest Income (Quarterly) (USD)|Aquestive Therapeutics Inc Price (USD)|Aquestive Therapeutics Inc Total Return Price (USD)|Aquestive Therapeutics Inc Enterprise Value (USD)|Aquestive Therapeutics Inc 30-Day Average Daily Volume|Aquestive Therapeutics Inc 1 Year Price Returns (Daily)|Aquestive Therapeutics Inc Short Interest|Aquestive Therapeutics Inc PE Ratio (Forward)|Aquestive Therapeutics Inc PE Ratio (Forward 1y)|Aquestive Therapeutics Inc PS Ratio (Forward)|Aquestive Therapeutics Inc PS Ratio (Forward 1y)|Aquestive Therapeutics Inc Quarterly EPS Estimates (USD)|Aquestive Therapeutics Inc Quarterly Revenue Estimates (USD)|Aquestive Therapeutics Inc Quarterly EPS Surprise|Aquestive Therapeutics Inc Quarterly Revenue Surprise|Aquestive Therapeutics Inc Quarterly Actual EPS (USD)|Aquestive Therapeutics Inc Quarterly Actual Revenue (USD)|Aquestive Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Aquestive Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Aquestive Therapeutics Inc Price Target (USD)|Aquestive Therapeutics Inc Consensus Recommendation|Aquestive Therapeutics Inc Price Target Num Estimates|Aquestive Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Aquestive Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Aquestive Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Aquestive Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Aquestive Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Aquestive Therapeutics Inc Land and Improvements (Quarterly) (USD)|Aquestive Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Aquestive Therapeutics Inc Other Properties (Quarterly) (USD)|Aquestive Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
russ2000_2_0044|AQST|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
russ2000_2_0044|AQST|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|daily|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
russ2000_2_0044|AQST|5|91.2666666667|91.2666666667|91.2666666667|91.2666666667|91.2666666667|91.2666666667|91.2666666667|91.2666666667||91.2666666667|91.2666666667||6.97326203209|91.3333333333|6.97326203209|91.3333333333|6.97326203209||1.45528455285|6.81547619048|91.2666666667|1.44888888889|91.3333333333|15.2380952381|91.2666666667|91.2666666667|91.2666666667|91.3333333333|91.3846153846|31.5714285714|30.5||30.5|91.3333333333|335.333333333|91.3333333333|91.3333333333|33.1388888889||91.2666666667|91.2666666667|91.2666666667|91.3333333333|91.3125|91.3571428571||91.2666666667|91.2666666667||91.3333333333|91.3333333333|91.3333333333|91.3333333333|91.3333333333|6.97326203209|6.97326203209|6.97326203209|6.97237569061|6.95555555556|15.2380952381||1.44117647059|1.44712430427|1.44712430427|91.3333333333|91.3333333333|91.2857142857|91.2857142857|91.2857142857|91.2857142857|15.2816901408|16.0657894737|15.8875|4.67279411765|15.8875|14.8630136986|16.28|91.3333333333|91.3333333333|91.3333333333|||91.3333333333|91.2666666667||
russ2000_2_0044|AQST|6|15|15|15|15|15|15|15|15||15|15||187|12|187|12|187||123|168|15|900|12|84|15|15|15|12|13|28|30||14|18|3|18|18|36||15|15|15|18|16|14||15|15||18|18|18|18|18|187|187|187|181|135|84||34|539|539|12|12|7|7|7|7|71|76|80|272|80|73|75|18|18|18|||6|15||
russ2000_2_0044|AQST|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
russ2000_2_0044|AQST|201703||||||||||||||||||||||||||||||||||20||-0.1035|6.128||||||-0.0825|||||||16.436|12.252|-1.457|-1.457|-1.818||||||||||||||||||||||||5.343|0.928|1.818||||||
russ2000_2_0044|AQST|201706||||||||||||||||||||||||||||||||||20||-0.3256|5.223||||||-0.3004|||||||11.142|6.001|-5.897|-5.897|-1.949||||||||||||||||||||||||4.837|0.949|1.949||||||
russ2000_2_0044|AQST|201709||||||||||||||||||||||||||||||||||20||0.3912|6.161||||||0.4225|||||||27.146|22.266|8.451|8.451|-1.97||||||||||||||||||||||||5.684|0.957|1.97||||||
russ2000_2_0044|AQST|201712|28.163|17.379|4.014|13.46|0.254|69.611|15.35|54.261||-107.366|-120.093||||||||||-1.7176||||6.179|9.973|80.871|||||||20||-0.5333|7.565|||24||1.5347|-0.4613||||-8.943|66.919||12.195|6.58|-10.04|-10.04|-1.97||||||||||||||||||||||||6.271|0.967|1.97||||23.273||
russ2000_2_0044|AQST|201803|30.421|16.488|3.85|12.764|0.241|68.902|23.472|45.43||-22.82|-23.201||||||||||-2.0142||||9.441|10.989|0.02|||||||20|195|0.2049|7.569|||24||1.1047|0.1701||||-3.387|73.894||23.411|17.775|4.099|4.099|-1.903||||||||||||||||||||||||4.901|0.953|1.927||||23.341||
russ2000_2_0044|AQST|201806|26.649|10.638|4.348|12.766|0.229|78.789|23.474|55.315||-38.948|-32.394||5.5949||52.9193||4.3955||||-1.1921|||0.0065|6.629|18.526|0.02|-205.3808|9|||||24||-1.5205|33.668|24.5||24||0.7356|-1.4431||||-33.983|76.68||13.928|8.955|-36.493|-36.493|-1.927|16.05|16.05|429.017|||1596||||||||||||85.8333|26.6667|2|3||-1.03|7.994|0.777|1.927||||23.623|16.9|
russ2000_2_0044|AQST|201809|77.359|63.982|4.483|12.211|0.216|66.566|21.329|45.237||23.444|-47.432||6.0582|-7.3002|58.286|4.6613|4.7077||16.0969||1.9964||-17.8768|0.588|7.45|14.376|0.025|-191.7539|7|||||23.6462||-0.64|12.346|24.9422||24.9422||3.3491|-0.4659|-68.714|||-57.472|62.801||13.267|7.675|-15.038|-15.038|-1.717|17.51|17.51|472.5247|163262.2667||146669||||||||||||85.178|28.25|1.75|4||-1.1433|4.534|0.746|1.933||||23.869|15.23|8.59
russ2000_2_0044|AQST|201812|74.201|60.599|5.441|12.207|0.204|76.771|32.952|43.819||10.08|-61.376||2.173|-2.3435|-7.1786|1.6561|2.1493||15.5983|-0.0074|4.6828||-49.7806|1.1475|6.481|23.339|0.025|-173.2122|9|||||24.8955|277|-0.56|18.71|24.9573||24.9573||2.0357|-0.56|-0.116|||-61.376|67.43||16.824|12.037|-13.944|-13.944|-1.588|6.16|6.16|136.466|165767.2333||286393|||||||||||59.983|58.2287|25.75|1.75|4|-2.15|-2.34|5.683|0.76|1.902||||24.41|7.92|6.48
russ2000_2_0044|AQST|201903|55.958|39.934|5.137|11.594|0.191|74.035|29.638|44.397||-6.056|-78.954||2.3607|-2.2473|-10.7446|2.6513|2.3708||17.1208|-0.0072|-7.8587||-40.1251|1.6819|7.489|19.501|0.025|-200.8097|7|||||24.9636||-0.59|17.908|24.9751||24.9751||1.6001|-0.59||||-80.201|56.662||12.643|9.137|-14.726|-14.726|-1.652|6.91|6.91|159.1812|122256.3333||420053|||||||||||39.6616|63.0048|21.6|1.6|5|-2.24|-1.7925|4.303|0.783|1.926||||24.712|5.78|4.06
russ2000_2_0044|AQST|201906|39.064|22.165|4.647|10.933|0.178|75.065|24.629|50.436||-24.657|-99.426||1.9864|-2.0312|-3.3702|2.5862|1.8069|||-0.001|-1.9238||-65.7725|3.7578|10.15|20.21|0.025|-160.9925|8|1|2.046|||24.9809||-0.82|16.246|25.0227||25.0227||1.3121|-0.82||||-64.18|53.863||11.129|5.709|-20.472|-20.472|-1.784|4.2|4.2|112.5534|123893.1667|-77.5701|938523|||||||||||40.6502|64.2797|19.6667|1.6667|6|-2.4633|-2.042|8.151|0.76|1.937||||24.712|3.48|3.83
russ2000_2_0044|AQST|201909|38.06|20.914|4.124|10.351|0.165|83.277|20.053|63.224||-34.459|-117.838||1.9151|-1.7541|-2.0403|2.4273|1.4216|||-0.0156|-1.7347||-3.4971|1.3|10.316|14.497|0.025|-155.5397|7|1|1.6354|||25.0315||-0.74|13.714|25.043||25.043||1.5574|-0.5444||||-67.554|53.014||12.418|7.775|-18.412|-18.412|-2.514|3.11|3.11|103.1515|112215.0667|-82.4379|325567|||||||||||43.9553|59.3017|18|1.6667|6|-2.7983|-2.2917|5.063|0.745|2.652||||24.848|4.03|7.21
russ2000_2_0044|AQST|201912|68.314|49.326|2.859|9.726|0.153|84.601|18.555|66.046||-6.122|-130.474||3.9223|-3.1149|-3.3898|2.6293|2.8051|||-0.2534|-9.8559||-1.3857|1.2696|13.13|12.574|0.034|-164.6862|8|4|2.8998|||26.4477|232|-0.48|16.474|33.5629||33.5629||3.366|-0.48||||-66.246|52.609||16.419|9.627|-12.636|-12.636|-2.732|5.82|5.82|206.3481|1540692.7667|-9.1133|426100|||4.3502|3.9781|-0.396|15.8415|-21.2121|3.6455|-0.48|16.419|52.0382|56.8528|18|1.6667|6|-2.3167|-1.932|3.057|0.617|2.803||||25.025|4.06|4.02
russ2000_2_0044|AQST|202003|51.088|35.521|3.087|12.971|0.14|85.316|15.362|69.954||-20.829|-147.004||1.6583|-1.454|-1.7486|1.5344|1.0941|||-0.1689|-2.9249||-3.7307|5.0774|9.536|10.653|0.034|-184.9808|7|2|2.9627|||33.5697||-0.49|14.613|33.5827||33.5827||2.933|-0.49||||-68.05|48.731||8.765|5.106|-16.53|-16.53|-2.669|2.27|2.27|87.2436|528724.4333|-62.5817|1705134|||1.6379|1.4978|-0.478|10.0725|-2.5105|-12.9809|-0.49|8.765|41.4033|78.4268|17.1667|1.6667|6|-1.892|-1.172|4.354|0.887|2.771|||3.912|25.081|4.16|5.16
russ2000_2_0044|AQST|202006|43.909|25.422|3.173|12.221|0.127|84.934|14.882|70.052||-21.388|-149.338||3.3649|-3.9962|-4.0362|3.1388|2.4317||||-2.8757||-1.7032|5.0974|12.891|8.787|0.034|-136.731|9|9|4.6992|||33.5892||-0.07|13.894|33.6166||33.6166||2.5745|-0.07||||-49.912|59.277||21.675|18.136|-2.334|-2.334|-2.729|4.86|4.86|199.4597|1202660.7667|15.7143|1713560|||3.6385|3.3272|-0.4433|8.766|84.2104|147.2621|-0.07|21.675|47.8427|74.5582|17.5|1.6667|6|-1.5083|-1.2683|3.847|0.797|2.747|||3.764|25.165|5.23|7.99
russ2000_2_0044|AQST|202009|31.684|17.064|3.242|11.337|0.115|86.942|18.373|68.569||-36.519|-165.889||3.1099|-4.3341|-3.7303|4.1302|2.2066||||-1.7004||-1.7965|5.5816|7.99|9.169|0.034|-129.644|8|9|4.9951||71.3137|33.6194||-0.49|11.803|33.6198||33.6198||1.3636|-0.49||||-48.051|55.119||8.26|5.282|-16.551|-16.551|-2.77|4.41|4.41|184.3463|1353247.6333|45.0658|1876531|||3.6351|3.3241|-0.432|8.723|-13.4259|-5.3078|-0.49|8.26|47.3523|53.2605|14.8333|1.6667|6|-1.43|-1.564|7.26|0.653|2.778|||3.609|25.501|5.4|6.62
russ2000_2_0044|AQST|202012|44.625|31.807|2.461|10.321|0.102|111.381|21.104|90.277||-48.497|-186.257||4.2022|-3.4068|-5.4005|3.0221|3.2026||||-0.761||-0.8872|4.8447|6.955|7.405|0.035|-187.9354|9|4|4.402||71.9517|33.826|187|-0.6|15.582|34.5693||34.5693||1.8367|-0.6|-6.215|||-55.783|45.849||7.149|4.361|-20.368|-20.368|-4.722|5.55|5.55|231.6219|649253|0.271|1674785|||3.7665|2.7824|-0.5275|6.2523|-15.6398|14.3414|-0.61|7.149|44.9023|81.1977|15|1.6667|6|-1.53|-0.705|4.425|1.106|4.726|||3.448|25.541|5.53|5.27
russ2000_2_0044|AQST|202103|44.443|27.498|2.799|9.556|0.089|113.721|20.05|93.671||-51.798|-200.929||3.6576|-3.6906|-3.6475|3.2139|3.2955||||-0.7347||-6.1816|7.8044|10.209|6.687|0.036|-335.1377|8|5|6.171||59.5846|35.5633||-0.41|13.231|36.2414||36.2414||1.8806|-0.41|-9.891|||-53.925|48.206||11.122|8.365|-14.672|-14.672|-6.147|4.49|4.49|167.6979|905306.7333|97.7974|2828436|||3.8379|2.8352|-0.432|8.9615|5.0926|24.1087|-0.41|11.122|39.1335|76.071|14.6667|1.6667|6|-1.736|-1.272|3.659|0.755|6.147|||3.277|21.876|4.18|3.38
russ2000_2_0044|AQST|202106|50.998|34.234|2.839|8.893|0.076|120.644|23.035|97.609||-53.769|-213.296||3.2629|-2.472|-3.3893|2.3641|2.8407|||-0.6575|-0.7294||-13.3099|6.2521|12.127|8.1|0.039|-1239.0159|9|1|4.2188||46.3755|37.0653||-0.33|13.134|38.5682||38.5682||2.0126|-0.33|-8.614|||-63.958|41.876||15.345|10.879|-12.367|-12.367|-5.85|4.01|4.01|157.2923|671466|-20.1195|2411308|||3.1182|2.3035|-0.442|9.4757|25.3394|61.9411|-0.33|15.345|40.0648|75.0327|14.6667|1.6667|6|-1.694|-1.202|4.262|0.742|6.223|||3.102|22.05|3.38|4.58
russ2000_2_0044|AQST|202109|50.21|31.164|2.863|8.114|0.064|125.638|25.039|100.599||-60.345|-227.851||4.3257|-2.9695|-4.7359|2.818|3.7882|||-0.8812|-0.6695||-15.2124|3.5605|13.643|6.215|0.04||8|2|2.2342||41.3868|39.2249||-0.37|12.129|40.0832||40.0832||1.7895|-0.37|-6.087|||-61.962|46.903||13.287|8.887|-14.555|-14.555|-6.587|4.53|4.53|181.1418|456176.9667|-8.8531|1427157|||3.5591|2.6292|-0.4725|11.006|21.6931|20.7251|-0.37|13.287|48.3212|68.8934|15.4|1.6|5|-1.685|-1.3125|4.726|0.736|6.587|||2.917|22.138|4.95|5.9
russ2000_2_0044|AQST|202112|||||||||||||3.5537||-4.2687||3.0439|||-0.1949||||3.4222||||||3|0.0094||44.7445||||||||||||||||||||||3.92|3.92|166.6769|932292.2|-31.2281|1374495||9.9744|2.4261|1.179|-0.49|9.362|||||49.1034|64.398|15|1.6|5|-1.5|-1.3825||||||||2.93|2.44
russ2000_2_0044|AQST|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.41|10.65||||||||||||||||||||
russ2000_2_0044|AQST|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.38|14.2||||||||||||||||||||
russ2000_2_0044|AQST|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.37|17.85||||||||||||||||||||
russ2000_2_0044|AQST|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.36|20.95||||||||||||||||||||